483
Lonza Biologics, Inc.FDA 483 - Lonza Biologics, Inc. - May 03, 2011
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
The FDA inspected Lonza Biologics, Inc. in Hopkinton, MA, a manufacturer of drug substance, revealing significant deficiencies. The firm failed to adequately investigate out-of-specification results, ensure timely completion of investigations, and maintain proper quality control over materials and processes for Ontak and Increlex drug substances. Additionally, issues were noted with equipment maintenance, cleaning validation, and comprehensive employee training.
Open in Dashboard
ID · 08a78762-4e0e-4a56-a33b-83627059e06a